Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Merck to pay Daiichi Sankyo up to $22bn to collaborate on 3 new cancer drugs
, /in E-News /by panglobalIn a deal potentially worth up to US$22 billion, Merck (known as MSD outside of the United States and Canada) has entered into a collaboration agreement with Japan-based Daiichi Sankyo to co-develop and co-commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates: patritumab deruxtecan (HER3-DXd), ifinatamab deruxtecan (I-DXd) and raludotatug deruxtecan (R-DXd).
Improving equity of diagnosis of ovarian cancer
, /in Featured Articles, Tumour Markers /by panglobalAlthough the prevalence of ovarian cancer is fairly low, it is often asymptomatic until after metastasis, resulting in it being the fourth leading cause of cancer death in females in the USA. The development of biomarker screening tests for ovarian cancer has been challenging and the situation is still not satisfactory. Additionally, the tests that […]
Breakthrough in automated tissue dissection for molecular pathology lab
, /in Featured Articles /by panglobalBy Dr Reinhold Wimberger-Friedl Analysis of tumour tissue for molecular biomarkers is a labour-intensive and time-consuming process, requiring precision at each of the many steps involved. This article discusses how recently launched technology is helping to improve sample selection and tissue dissection.
Utility of human chorionic gonadotropin as a tumour marker
, /in Featured Articles /by panglobalBy Rosa Ferrer, Andrea Mansilla and Maria Costa The role of human chorionic gonadotropin in pregnancy has been extensively studied for many years. However, the importance of this hormone goes beyond pregnancy. It can also be used as a biomarker, mainly in trophoblastic tumours, but as will be shown later in this article, its importance […]
PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment
, /in E-News /by panglobalClinical Trial Application filed for combined drug targeting amyloid deposits associated with Alzheimer’s Disease.
Non-invasive device for monitoring ultra-low fluid flows
, /in Product News /by panglobalThe Micro Flow Meter from Biotech Fluidics is a new device designed to continuously monitor ultra-low fluidic flows in real-time.
Fapon and Halodoc Forge Strategic Partnership to Drive the Development of Indonesia’s In-Vitro Diagnostics Industry
, /in E-News /by panglobalFapon, a leading life-science organization, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform in Indonesia. This partnership brings together Fapon’s expertise in in-vitro diagnostics (IVD) technologies and integrated solutions with Halodoc’s strong sales channels and local service provisions. The partnership aims to enhance the healthcare standards in Indonesia, benefit local communities, and […]
Streamlining Biospecimen Sample Management
, /in Events /by panglobalAzenta Life Sciences latest exciting products for biospecimen sample management will be on show at ISBER 2023 in Granada, Spain (24th-25th October).
The London Clinic celebrates opening of £4m blood sciences pathology lab
, /in Product News /by panglobalThe pathology laboratory has been fitted out with industry gold standard equipment including ground-breaking technology in the diagnosis of cancer conditions which will enable a far greater volume of accurate tests to be processed, around the clock, seven days a week.
Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows
, /in Product News /by panglobalInvestment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions